Page last updated: 2024-08-23

etoposide and valganciclovir

etoposide has been researched along with valganciclovir in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Oksenhendler, E	1
Achermann, Y; Fehr, J; Lederer, H; Stenner, F; Tinguely, M	1
Doğu, MH; Eren, R; Gündoğan, C; Huq, GE; Kantarci, FE; Suyanı, E	1
Halliday, M; Ross, J; Southgate, WM	1

Reviews

2 review(s) available for etoposide and valganciclovir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
HIV-associated multicentric Castleman disease. Current opinion in HIV and AIDS, 2009, Volume: 4, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication	2009

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

HIV-associated multicentric Castleman disease.

Current opinion in HIV and AIDS, 2009, Volume: 4, Issue:1

Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication

2009

Other Studies

3 other study(ies) available for etoposide and valganciclovir

Article	Year
Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man. Infection, 2012, Volume: 40, Issue:2 Topics: Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antiviral Agents; Castleman Disease; Drug Therapy, Combination; Etoposide; Ganciclovir; HIV Infections; Humans; Immunologic Factors; Male; Middle Aged; Rituximab; Seizures, Febrile; Treatment Outcome; Valganciclovir	2012
A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:7 Topics: Antiviral Agents; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Ganciclovir; Herpesvirus 8, Human; Humans; Male; Middle Aged; Prednisolone; Rituximab; Valganciclovir; Vincristine	2016
Cytomegalovirus-Induced Hemophagocytic Lymphohistiocytosis in an Extreme Preterm Infant: Recognition and Therapy Leading to Recovery. Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2017, Volume: 17, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Antiviral Agents; Bone Marrow; Cyclosporine; Cytomegalovirus Infections; Dexamethasone; Etoposide; Ganciclovir; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Infant, Extremely Premature; Infant, Newborn; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Male; Receptors, Interleukin-2; Treatment Outcome; Valganciclovir	2017